Journal of Reproductive Immunology
Volume 84, Issue 2 , Pages 199-205 , March 2010

Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression

  • Irene Velasco

      Affiliations

    • Division of Gynecology, School of Medicine, Miguel Hernández University, 03550 Alicante, Spain
    • Service of Obstetrics and Gynecology, San Juan University Hospital, 03550 Alicante, Spain
    • Corresponding Author InformationCorresponding author at: División de Ginecología, Facultad de Medicina, Universidad Miguel Hernández, Campus de San Juan, Apdo. 18, 03550 San Juan, Alicante, Spain. Fax: +34 965919550.
    • ,
  • Pedro Acién

      Affiliations

    • Division of Gynecology, School of Medicine, Miguel Hernández University, 03550 Alicante, Spain
    • Service of Obstetrics and Gynecology, San Juan University Hospital, 03550 Alicante, Spain
    • ,
  • Adolfo Campos

      Affiliations

    • Division of Immunology, School of Medicine, Miguel Hernández University, 03550 Alicante, Spain
    • Blood Bank Centre of Alicante, 03550 Alicante, Spain
    • ,
  • María Isabel Acién

      Affiliations

    • Division of Gynecology, School of Medicine, Miguel Hernández University, 03550 Alicante, Spain
    • Service of Obstetrics and Gynecology, San Juan University Hospital, 03550 Alicante, Spain
    • ,
  • Eva Ruiz-Maciá

      Affiliations

    • Division of Gynecology, School of Medicine, Miguel Hernández University, 03550 Alicante, Spain
    • Service of Obstetrics and Gynecology, San Juan University Hospital, 03550 Alicante, Spain

Received 18 September 2009 ,Revised 25 November 2009 ,Accepted 30 November 2009.

References 

  1. Acién P, Quereda FJ, Gómez-Torres MJ, Bermejo R, Gutiérrez M. GnRH analogues, transvaginal ultrasound-guided drainage and intracystic injection of recombinant interleukin-2 in the treatment of endometriosis. Gynecol. Obstet. Invest. 2003;55:95–103
  2. Acién P, Pérez-Albert G, Quereda F, Sánchez-Ferrer M, García-Almela A, Velasco I. Treatment of endometriosis with transvaginal ultrasound-guided drainage under GnRH analogues and recombinant interleukin-2 left in the cysts. Gynecol. Obstet. Invest. 2005;60:224–231
  3. Acién P, Velasco I, Gutiérrez M, Martínez-Beltrán M. Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings. Fertil. Steril. 2007;88:32–38
  4. Akoum A, Lawson C, McColl S, Villeneuve M. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol. Hum. Reprod. 2001;7:859–866
  5. Amaral VF, Ferriani RA, Sá MF, Nogueira AA, Rosa e Silva JC, Rosa e Silva AC, et al. Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis. Sao Paulo Med. J. 2006;124:223–227
  6. American Society for Reproductive Medicine . Revised American Society for Reproductive Medicine classification of endometriosis. Fertil. Steril. 1996;67:817–821
  7. Arici A, Seli E, Zeyneloglu HB, Senturk LM, Oral E, Olive DL. Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. J. Clin. Endocrinol. Metab. 1998;83:1201–1205
  8. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum. Reprod. 2002;17:426–431
  9. Bedaiwy MA, El-Nashar SA, Sharma RK, Falcone T. Effect of ovarian involvement on peritoneal fluid cytokine concentrations in endometriosis patients. Reprod. Biomed. Online. 2007;14:620–625
  10. Bulmer JN, Jones RK, Searle RF. Intraepithelial leukocytes in endometriosis and adenomyosis: comparison of eutopic and ectopic endometrium with normal endometrium. Hum. Reprod. 1998;13:2910–2915
  11. Colette S, Lousse JC, Defrère S, Curaba M, Heilier JF, Van Langendonckt A, et al. Absence of aromatase protein and mRNA expression in endometriosis. Hum. Reprod. 2009;24:2133–2141
  12. Edwards RR, Kronfli T, Haythornthwaite JA, Smith MT, McGuire L, Page GG. Association of catastrophizing with interleukin-6 responses to acute pain. Pain. 2008;140:135–144
  13. Falconer H, Bambra CS, Chai D, Cornillie FJ, Hill JA, D’Hooghe TM. The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons. Hum. Reprod. 2005;20:3033–3038
  14. Gallinelli A, Chiossi G, Giannella L, Marsella T, Genazzani AD, Volpe A. Different concentrations of interleukins in the peritoneal fluid women with endometriosis: relationship with lymphocyte subsets. Gynecol. Endocrinol. 2004;18:144–151
  15. Gómez-Torres MJ, Acién P, Campos A, Velasco I. Embryotoxicity of peritoneal fluid in women with endometriosis. Its relation with cytokines and lymphocyte populations. Hum. Reprod. 2002;17:777–781
  16. Hirata T, Osuga Y, Hamasaki K, Yoshino O, Ito M, Hasegawa A, et al. Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygenase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology. 2008;149:1260–1267
  17. Ismail MA, Rotmensch J, Mercer LJ, Block BS, Salti GI, Holt JA. CA-125 in peritoneal fluid from patients with nonmalignant gynecologic disorders. J. Reprod. Med. 1994;39:510–512
  18. Keenan JA, Chen TT, Chadwell NL, Torry DS, Caudle MR. Interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am. J. Reprod. Immunol. 1994;32:180–183
  19. Keenan JA, Chen TT, Chadwell NL, Torry DS, Caudle MR. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am. J. Reprod. Immunol. 1995;34:381–385
  20. Koninckx PR, Muyldermans M, Moerman P, Meuleman C, Deprest J, Cornillie F. CA 125 concentrations in ovarian ‘chocolate’ cyst fluid can differentiate an endometriotic cyst from a cystic corpus luteum. Hum. Reprod. 1992;7:1314–1317
  21. Martínez S, Garrido N, Coperias JL, Pardo F, Desco J, García-Velasco JA, et al. Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum. Reprod. 2007;22:836–842
  22. Matalliotakis IM, Goumenou AG, Mulayim N, Karkavitsas N, Koumantakis EE. High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis. Arch. Gynecol. Obstet. 2005;271:40–45
  23. McLaren J, Dealtry G, Prentice A, Charnock-Jones DS, Smith SK. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis. Hum. Reprod. 1997;12:1307–1310
  24. Mulayim N, Savlu A, Guzeloglu-Kayisli O, Kayisli UA, Arici A. Regulation of endometrial stromal cell matrix metalloproteinase activity and invasiveness by interleukin-8. Fertil. Steril. 2004;81:904–911
  25. Nisolle M, Casanas-Roux F, Donnez J. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil. Steril. 1997;68:912–919
  26. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J. Clin. Endocrinol. Metab. 1996;81:174–179
  27. Noble LS, Takayama K, Zeitoun KM, Putman JM, Johns DA, Hinshelwood MM, et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J. Clin. Endocrinol. Metab. 1997;82:600–606
  28. Singh A, Purohit A, Duncan LJ, Mokbel K, Ghilchick MW, Reed MJ. Control of aromatase activity in breast tumours: the role of the immune system. J. Steroid Biochem. Mol. Biol. 1997;61:185–192
  29. Tariverdian N, Theoharides TC, Siedentopf F, Gutiérrez G, Jeschke U, Rabinovich GA, et al. Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin. Immunopathol. 2007;29:193–210
  30. Tsudo T, Harada T, Iwabe T, Tanikawa M, Nagano Y, Ito M, et al. Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues. Fertil. Steril. 2000;73:205–211
  31. Velasco I, Campos A, Acién P. Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage, and intracystic recombinant interleukin-2. Fertil. Steril. 2005;83:873–877
  32. Velasco I, Rueda J, Acién P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol. Hum. Reprod. 2006;12:377–381
  33. Wilson TJ, Hertzog PJ, Angus D, Munnery L, Wood EC, Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil. Steril. 1994;62:1086–1088
  34. Witz CA, Montoya IA, Dey TD, Schenken RS. Characterization of lymphocyte subpopulations and T cell activation in endometriosis. Am. J. Reprod. Immunol. 1994;32:173–179
  35. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, et al. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 1995;155:5483–5486
  36. Zeitoun D, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, et al. Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17β-estradiol. J. Clin. Endocrinol. Metab. 1999;83:4474–4480
  37. Zhang X, Xu H, Lin J, Qian Y, Deng L. Peritoneal fluid concentrations of interleukin-17 correlate with the severity of endometriosis and infertility of this disorder. B.J.O.G. 2005;112:1153–1155

PII: S0165-0378(09)00554-3

doi: 10.1016/j.jri.2009.11.004

Journal of Reproductive Immunology
Volume 84, Issue 2 , Pages 199-205 , March 2010

Article Tools

* Image Usage & Resolution